ArticleCancers2021

Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study.

Shigeo Shimose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.